Reach Us +44-1647-403003
Imad Al-Sabri | OMICS International
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Imad Al-Sabri


Valsartan Attenuates Cardiotoxicity in Breast Cancer Patients A fter Chemotherapy

Objective: To determine whether valsartan would be useful in attenuating Adriamycin/Cyclophosphamide/ Herceptin (ACH)-induced cardiotoxicity and to assess the role of biomarkers as indicators of cardiotoxicity in patients with breast cancer undergoing cancer therapy.Background: Valsartan is indicated to reduce the risk of cardiovascular death and h... Read More»

Nawal A Al-Hamadi, Imad Al-Sabri, Amina B Aldujele, Salam J Al-Fatlawi and Zuhair Allebban

Review Article: J Cancer Sci Ther/Vol.10.5 105(2018)

DOI: 10.4172/1948-5956.1000526

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Relevant Topics